Vicore Pharma Holding AB (publ) - Asset Resilience Ratio

Latest as of December 2025: 48.38%

Vicore Pharma Holding AB (publ) (VICO) has an Asset Resilience Ratio of 48.38% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr590.06 Million

≈ $63.50 Million USD Cash + Short-term Investments

Total Assets

Skr1.22 Billion

≈ $131.25 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Vicore Pharma Holding AB (publ)'s Asset Resilience Ratio has changed over time. Check VICO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Vicore Pharma Holding AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Vicore Pharma Holding AB (publ) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr590.06 Million	48.38%
Total Liquid Assets	Skr590.06 Million	48.38%

Asset Resilience Insights

Very High Liquidity: Vicore Pharma Holding AB (publ) maintains exceptional liquid asset reserves at 48.38% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Vicore Pharma Holding AB (publ) Industry Peers by Asset Resilience Ratio

Compare Vicore Pharma Holding AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Vicore Pharma Holding AB (publ) (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Vicore Pharma Holding AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	48.38%	Skr590.06 Million ≈ $63.50 Million	Skr1.22 Billion ≈ $131.25 Million	--
2024-12-31	0.00%	Skr0.00 ≈ $0.00	Skr1.20 Billion ≈ $129.47 Million	--
2023-12-31	29.94%	Skr149.04 Million ≈ $16.04 Million	Skr497.84 Million ≈ $53.58 Million	+28.48pp
2022-12-31	1.46%	Skr4.94 Million ≈ $531.62K	Skr338.01 Million ≈ $36.37 Million	-15.61pp
2021-12-31	17.07%	Skr77.00 Million ≈ $8.29 Million	Skr451.17 Million ≈ $48.55 Million	-0.15pp
2020-12-31	17.22%	Skr70.00 Million ≈ $7.53 Million	Skr406.51 Million ≈ $43.75 Million	-5.35pp
2019-12-31	22.57%	Skr77.00 Million ≈ $8.29 Million	Skr341.11 Million ≈ $36.71 Million	+22.57pp
2018-12-31	0.01%	Skr21.00K ≈ $2.26K	Skr301.60 Million ≈ $32.46 Million	--

pp = percentage points

About Vicore Pharma Holding AB (publ)

ST:VICO Sweden Biotechnology

Market Cap

$325.99 Million

Skr3.03 Billion SEK

Market Cap Rank

#14307 Global

#239 in Sweden

Share Price

Skr10.76

Change (1 day)

-3.24%

52-Week Range

Skr9.47 - Skr15.68

All Time High

Skr37.60